Roelen Keetie, Ackley Caroline, Boyce Paul, Farina Nicolas, Ripoll Santiago
Institute of Development Studies (IDS), University of Sussex, Library Road, Brighton, BN1 9RE UK.
Global Health Research Unit, Brighton and Sussex Medical School, University of Sussex, Brighton, BN1 9PX UK.
Eur J Dev Res. 2020;32(5):1592-1612. doi: 10.1057/s41287-020-00316-6. Epub 2020 Oct 21.
COVID-19 has caused unprecedented health, economic and societal impacts across the world, including many low- and middle-income countries (LMICs). The pandemic and its fallout have laid bare deep-seated social and economic inequalities with marginalised groups being at greater risk of infection and being disproportionately affected by containment measures and their socioeconomic consequences. Stigma is a central element to such inequalities but remains largely overlooked in the debate on the response to COVID-19, including in LMICs. Yet we know from experiences with other infectious diseases such as HIV/AIDS and Ebola that disease-related stigma is detrimental to halting and controlling pandemics and achieving equitable development. Emerging evidence suggests that stigma associated with COVID-19 is already taking hold. This paper assesses potential driving factors of COVID-19-related stigma, and how this intersects with existing stigma fault lines and explores mechanisms through which COVID-19-related stigma may be counteracted, with a focus on LMICs.
新冠疫情在全球范围内造成了前所未有的健康、经济和社会影响，许多低收入和中等收入国家（中低收入国家）也未能幸免。这场大流行及其后果暴露了深层次的社会和经济不平等，边缘化群体感染风险更高，且在更大程度上受到防控措施及其社会经济后果的影响。污名化是此类不平等现象的核心要素，但在关于应对新冠疫情的讨论中，包括在中低收入国家，污名化很大程度上仍被忽视。然而，从艾滋病病毒/艾滋病和埃博拉等其他传染病的经验中我们了解到，与疾病相关的污名化不利于阻止和控制大流行以及实现公平发展。新出现的证据表明，与新冠疫情相关的污名化已经开始显现。本文评估了与新冠疫情相关污名化的潜在驱动因素，以及它如何与现有的污名化断层线相互交织，并探讨了应对与新冠疫情相关污名化的机制，重点关注中低收入国家。
